A new generation of efficient drugs for the modulation of the insulin biosynthesis

Extensive research into the very core of the so-called “lifestyle” disease diabetes mellitus type 2 has enabled the identification of three target proteins and their link to the pancreatic duodenal homeobox-1 protein (PDX-1), crucial for the insulin biosynthesis process. Their identification enables novel ways for research to develop new drugs for influencing the bodily function to produce insulin.

Further Information: PDF

PVA Mecklenburg-Vorpommern AG
Phone: +49 (0)381/49 74 74 0

Contact
Antonio Martinez

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Silicon Carbide Innovation Alliance to drive industrial-scale semiconductor work

Known for its ability to withstand extreme environments and high voltages, silicon carbide (SiC) is a semiconducting material made up of silicon and carbon atoms arranged into crystals that is…

New SPECT/CT technique shows impressive biomarker identification

…offers increased access for prostate cancer patients. A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more…

How 3D printers can give robots a soft touch

Soft skin coverings and touch sensors have emerged as a promising feature for robots that are both safer and more intuitive for human interaction, but they are expensive and difficult…

Partners & Sponsors